Webinar: Why Patient-Specific Insulin Dosing Matters. Watch for free today!
Blog
Inpatient Glucose Management: Part 1
Risks and Complications
Risks and complications associated with inpatient glucose control spark some of the most dreaded conversations exchanged in healthcare. Clinicians are accustomed with these situations and would prefer little or no occurrence. The detrimental obstacles include:
- Hyperglycemia – High blood sugar in hospitalized patients is common and associated with increased risk of infection, mortality and escalated cost.
- Hypoglycemia – Low blood sugar in hospitalized patients is the most common acute adverse effect of glucose-lowering therapy among patients with diabetes mellitus. Hypoglycemia is also associated with poor outcomes.
- Poor treatment and/or lack of control – Poor glucose management is directly linked to higher hyperglycemia and hypoglycemia rates, and poor manifestation of glucose control leads to lower reimbursements, poor outcomes and mortality.
- Hospital-acquired conditions – Manifestations of poor glycemic control include diabetic ketoacidosis (DKA), nonketotic hyperosmolar coma, hypoglycemic coma, secondary diabetes with ketoacidosis, and secondary diabetes with hyperosmolarity.
In our upcoming blogs, we will discuss the American Diabetes Association and Joint Commission guidelines on best practices for overcoming these risks and complications.
Related posts

Blog
Celebrating Nurses Who Lead: Why Nurse-Led Training Sets the Standard
Celebrating Nurses Who Lead: Why Nurse-Led Training Sets the Standard
Honoring Nurse Educators for National Nurses Week As we celebrate National Nurses Week, we're shining a light on the incredible work nurses do every day—not just at the bedside, but also as educators, leaders, and change agents. At Monarch Medical ...

Blog
Every 30 Seconds: The Decision Pressure Nurses Face
Every 30 Seconds: The Decision Pressure Nurses Face
Honoring Nurses Week 2025 Every May, we take a moment to celebrate the nurses who are the backbone of our healthcare system. But their impact isn't just something to recognize once a year - it's felt every second of every ...

News
Monarch Medical Technologies Announces FDA Clearance of EndoTool IV 3.1 with Dosing Mode For Hyperglycemic Crisis Management
Monarch Medical Technologies Announces FDA Clearance of EndoTool IV 3.1 with Dosing Mode For Hyperglycemic Crisis Management
Strengthening Hospital Response to Hyperglycemic Crisis: EndoTool may be used in the treatment of hyperglycemic crises, including conditions such as Euglycemic DKA (EuDKA), DKA, and HHNK. Monarch Medical Technologies, the only patient-specific insulin dosing solution for hospitals, today announced FDA ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields